BNP Paribas Financial Markets’s Evotec EVO Stock Holding History
Bought
Maintained
Sold
Other funds holding EVO
DA
AA
OMC
FC
BNP Paribas Financial Markets's EVO Position: Q2 2026 in Review
BNP Paribas Financial Markets reduced its Evotec (EVO) stake by 13% in Q2 2026, selling an estimated $5.79K and leaving 13,277 shares worth $37.2K. The position accounts for ﹤0.01% of the portfolio, ranked #5027.
BNP Paribas Financial Markets first reported a position in EVO in Q4 2024 and has held it in 7 quarters since. The position peaked at $50.4K in Q2 2025. 33 funds tracked by Wall St. Rank hold EVO as of Q2 2026.
- BNP Paribas Financial Markets held 13,277 shares of Evotec worth $37.2K as of Q2 2026.
- BNP Paribas Financial Markets sold 2,002 Evotec shares in Q2 2026, an estimated $5.79K.
- Evotec made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5027 holding.
- BNP Paribas Financial Markets first reported a position in Evotec in Q4 2024 and has held it in 7 quarters since.
- BNP Paribas Financial Markets's Evotec position peaked at $50.4K in Q2 2025.
- 33 funds tracked by Wall St. Rank held Evotec as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.